Team,

Today, the U.S. Supreme Court threw out anti-abortion advocates' claims that could have severely restricted access to the abortion pill mifepristone—a safe and effective medication that was approved by the FDA over 20 years ago.

Access to medication abortion remains unchanged for now, but we know that the attacks will continue.

I’m both relieved and angry: this is the right decision, but it's not a 'win' for abortion—it just maintains the status quo at a time when 14 states have already banned abortion entirely, and many more ban abortion as early as six weeks of pregnancy. Despite the Court's ruling today, medication abortion remains subject to state abortion bans and restrictions.

This case never should have gotten this far—as we've said before it had no basis in fact or law and the lower courts should never have let it go forward.

While we wait for the Court to decide another critical abortion case this session, your support will fuel the Center's fight to protect abortion access no matter the threat. Are you with us?

Onward,

Nancy Northup
President & CEO